The clinical significance of the FSH-LH ratio in gonadotropin preparations of human origin. A review.
D006063:Chorionic Gonadotropin / Q000592:standards; D004357:Drug Synergism; D004967:Estrogens / Q000096:biosynthesis; D005260:Female; D005640:Follicle Stimulating Hormone / Q000592:standards / Q000627:therapeutic use*; D006065:Gonadotropins, Pituitary / Q000008:administration & dosage / Q000032:analysis / Q000627:therapeutic use*; D006801:Humans; D007246:Infertility / Q000188:drug therapy*; D007986:Luteinizing Hormone / Q000592:standards / Q000627:therapeutic use*; D008297:Male; D010060:Ovulation / Q000187:drug effects; D011247:Pregnancy; D014427:Twins
D006063:Chorionic Gonadotropin; D004967:Estrogens; D006065:Gonadotropins, Pituitary; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone